Literature DB >> 20146282

The hERG potassium channel and drug trapping: insight from docking studies with propafenone derivatives.

Khac-Minh Thai1, Andreas Windisch, Daniela Stork, Anna Weinzinger, Andrea Schiesaro, Robert H Guy, Eugen N Timin, Steffen Hering, Gerhard F Ecker.   

Abstract

The inner cavity of the hERG potassium ion channel can accommodate large, structurally diverse compounds that can be trapped in the channel by closure of the activation gate. A small set of propafenone derivatives was synthesized, and both use-dependency and recovery from block were tested in order to gain insight into the behavior of these compounds with respect to trapping and non-trapping. Ligand-protein docking into homology models of the closed and open state of the hERG channel provides the first evidence for the molecular basis of drug trapping.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146282     DOI: 10.1002/cmdc.200900374

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  5 in total

Review 1.  In silico toxicology: From structure-activity relationships towards deep learning and adverse outcome pathways.

Authors:  Jennifer Hemmerich; Gerhard F Ecker
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2020-03-31

Review 2.  Modelling three-dimensional protein structures for applications in drug design.

Authors:  Tobias Schmidt; Andreas Bergner; Torsten Schwede
Journal:  Drug Discov Today       Date:  2013-11-08       Impact factor: 7.851

3.  Trapping and dissociation of propafenone derivatives in HERG channels.

Authors:  A Windisch; En Timin; T Schwarz; D Stork-Riedler; T Erker; Gf Ecker; S Hering
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  How to solve the problems of docking into a symmetric binding site: the example of the HERG channel.

Authors:  Andrea Schiesaro; Lars Richter; Gerhard F Ecker
Journal:  Sci Pharm       Date:  2013-07-31

5.  Drug trapping in hERG K+ channels: (not) a matter of drug size?

Authors:  Tobias Linder; Harald Bernsteiner; Priyanka Saxena; Florian Bauer; Thomas Erker; Eugen Timin; Steffen Hering; Anna Stary-Weinzinger
Journal:  Medchemcomm       Date:  2015-12-22       Impact factor: 5.121

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.